Product How it works Pricing Blog FAQ About Contact
Zenas BioPharma

Zenas BioPharma (NASDAQ: ZBIO) revenue

Zenas BioPharma reported revenue of $10.0m for fiscal 2025, 100.0% more than in fiscal 2024 ($5.0m). Since fiscal 2023 its revenue has fallen by 80.0%, an average decline of 55.3% a year.

Zenas BioPharma's best year of the last 3 was fiscal 2023. The biggest drop was in fiscal 2024, −90.0%.

Revenue, in millions of US dollars50.020235.0202410.02025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$10.0m+100.0%−$383.1m−3,830.6%
2024$5.0m−90.0%−$163.9m−3,277.8%
2023$50.0m—−$37.1m−74.3%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Zenas BioPharma revenue compared with its sector

By revenue for its latest fiscal year, Zenas BioPharma ranks 368th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Zenas BioPharma, 100.0%.

RankCompanyRevenueRevenue growth
366thCrescent Biopharma$10.8m—
367thJanux Therapeutics$10.0m−5.6%
368thZenas BioPharma$10.0m100.0%
369thTaysha Gene Therapies$9.8m17.3%
370thPrecigen$9.7m146.7%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Zenas BioPharma

How much revenue did Zenas BioPharma make in fiscal 2025?
Zenas BioPharma reported revenue of $10.0m for fiscal 2025, compared with $5.0m in fiscal 2024.
How much has the revenue of Zenas BioPharma fallen?
Between fiscal 2023 and fiscal 2025 it went from $50.0m to $10.0m: 80.0% less, an average decline of 55.3% a year.
What was the best year for revenue at Zenas BioPharma?
Of its last 3 fiscal years, fiscal 2023, with $50.0m.
Where does Zenas BioPharma rank in its sector by revenue?
It ranks 368th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Zenas BioPharma come from?
From the annual report (Form 10-K) that Zenas BioPharma files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Zenas BioPharma files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023. More on Zenas BioPharma: the Zenas BioPharma page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.